US20160015504A1 - Apparatus and method for repairing vaginal reconstruction - Google Patents

Apparatus and method for repairing vaginal reconstruction Download PDF

Info

Publication number
US20160015504A1
US20160015504A1 US14/867,593 US201514867593A US2016015504A1 US 20160015504 A1 US20160015504 A1 US 20160015504A1 US 201514867593 A US201514867593 A US 201514867593A US 2016015504 A1 US2016015504 A1 US 2016015504A1
Authority
US
United States
Prior art keywords
tissue
support portion
implant
vaginal
vagina
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/867,593
Inventor
Ajay Rane
Malcolm I. Frazer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astora Womens Health LLC
Original Assignee
Astora Womens Health LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astora Womens Health LLC filed Critical Astora Womens Health LLC
Priority to US14/867,593 priority Critical patent/US20160015504A1/en
Assigned to AMS RESEARCH, LLC reassignment AMS RESEARCH, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: AMS RESEARCH CORPATION
Assigned to APHRODITE WOMEN'S HEALTH, LLC reassignment APHRODITE WOMEN'S HEALTH, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMS RESEARCH, LLC
Assigned to ASTORA WOMEN'S HEALTH, LLC reassignment ASTORA WOMEN'S HEALTH, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: APHRODITE WOMEN'S HEALTH, LLC
Publication of US20160015504A1 publication Critical patent/US20160015504A1/en
Assigned to AMS RESEARCH, LLC reassignment AMS RESEARCH, LLC CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME. Assignors: AMS RESEARCH CORPORATION
Assigned to WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE reassignment WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ASTORA WOMEN'S HEALTH, LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06066Needles, e.g. needle tip configurations
    • A61B17/06109Big needles, either gripped by hand or connectable to a handle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0004Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse
    • A61F2/0031Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra
    • A61F2/0036Closure means for urethra or rectum, i.e. anti-incontinence devices or support slings against pelvic prolapse for constricting the lumen; Support slings for the urethra implantable
    • A61F2/0045Support slings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/04Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
    • A61B17/06Needles ; Sutures; Needle-suture combinations; Holders or packages for needles or suture materials
    • A61B17/06166Sutures
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/0063Implantable repair or support meshes, e.g. hernia meshes
    • A61F2002/0072Delivery tools therefor

Definitions

  • Anterior vaginal prolapse repairs have historically had recurrence rates of around thirty percent. This is because traditional surgery uses devitalized tissues and paravaginal defects are very difficult to correct transvaginally. Laparoscopic paravaginal defect correction is technically very difficult and there is no data looking at its efficacy.
  • the use of “mesh” for prolapse repair shows greater efficacy in a randomized trial by Sand et al. but does not address total anterior vaginal reconstruction and certainly not paravaginal defect correction.
  • the invention relates to treatments of vaginal prolapse of the types referred to as anterior vaginal prolapse, cystocele, lateral defects, and paravaginal defects.
  • mesh implants are provided and placed in a pelvic region to support vaginal tissue, bladder tissue, or both, either directly or by supporting tissue that would otherwise support the bladder or vaginal tissue.
  • a paravaginal defect is a defect of tissue that supports the bladder in a position superior to the vagina. This type of defect can cause the bladder to fall into the vagina and result in vaginal prolapse, including anterior vaginal prolapse such as cystocele, or a lateral defect.
  • An example of a paravaginal defect is a defect in the hammock-type tissue (e.g., pubocervical fascia) that supports the bladder, such as a tear or detachment of the tissue at a “tree end” of the tissue (e.g., the portion of the fascia away from the vaginal tissue, near the arcus tendineus) rather than a tear in the sheet (midline defect).
  • a specific example of a paravaginal defect can be torn pubocervical fascia along or near an arcus tendineus.
  • the defect may be unilateral or bilateral, either way resulting in a cystocoele.
  • a lateral defect e.g., paravaginal defect
  • Implants and methods of the present description can treat such conditions by supporting or replacing one or more of vaginal tissue, bladder tissue, or vaginal support tissue or bladder support tissue (e.g., pubocervical fascia).
  • the vaginal sulcus is the lateral depth of vagina in the anterior compartment.
  • the vaginal sulcus is usually between 2 and 5 centimeters deep and increases in depth as the vagina extends in a posterior direction.
  • Advantages of the present invention include reconstructing the arcus tendineus with prolene, thereby giving strength. Another advantage includes providing more anatomical repair. The procedure is a minimally invasive technique when compared with abdominal paravaginal repair.
  • the invention relates to an implantable device useful for treating vaginal prolapse including a paravaginal defect.
  • the device includes a mesh support portion and multiple mesh extension portions, the support portion is capable of supporting a bladder.
  • Each extension portion is capable of extending to tissue of an obturator foramen while the support portion supports the bladder.
  • the invention in another aspect, relates to a system for treating vaginal prolapse.
  • the system includes two implants.
  • Each implant includes a mesh support portion and two mesh extension portions.
  • the support portion is capable of contacting vaginal sulcus tissue while the two extension portions extend to tissue of an obturator foramen.
  • the invention in another aspect, relates to a method of treating cystocele related to a lateral vaginal defect.
  • the method includes: providing an implant as described herein; making an upper vaginal midline incision; passing the implant through the vaginal incision; placing the mesh support portion in a position superior to vaginal tissue, to support a bladder; making a superior left external incision at an inner thigh adjacent to a left obturator foramen, preparing a tissue path between the superior left external incision and the lateral vaginal tissue on a left side of the vagina, passing an extension portion through the tissue path between the superior left external incision and the lateral vaginal tissue on the left side of the vagina; making an inferior left external incision at an inner thigh adjacent to a left obturator foramen, preparing a tissue path between the inferior left external incision and the lateral vaginal tissue on a left side of the vagina, passing an extension portion through the tissue path between the inferior left external incision and the
  • the invention in another aspect, relates to a method of treating cystocele, including treating a lateral vaginal defect.
  • the method includes: providing a system of implants as described; making an upper vaginal midline incision; passing a first implant of the system through the vaginal incision; placing a mesh support portion of the first implant in contact with lateral vaginal tissue on a left side of the vagina; making a superior left external incision at an inner thigh adjacent to a left obturator foramen, preparing a tissue path between the superior left external incision and the lateral vaginal tissue on a left side of the vagina, passing a first extension portion of the first implant through the tissue path between the superior left external incision and the lateral vaginal tissue on the left side of the vagina; making an inferior left external incision at an inner thigh adjacent to a left obturator foramen, preparing a tissue path between the inferior left external incision and the lateral vaginal tissue on a left side of the va
  • FIG. 1A is a perspective view of an embodiment of an implant as described, at least partially implanted in an illustrated pelvis.
  • FIGS. 1B-1E are various configurations of implants as described.
  • FIG. 2 illustrates a system or kit as described, including two implants.
  • FIGS. 3A and 3B illustrate examples of needles useful according to methods described herein.
  • FIG. 4 is a perspective view of an embodiment of a system of implants as described.
  • An implant can generally include a support portion that contacts tissue to be supported, and two or more opposing extension portions that extend away from the support portion.
  • support portion and “extension portion” can be used specifically or generally to denote precise or general portions of an implant.
  • Exemplary implants may be in the form of a continuous mesh tape that includes a support portion located at the center of the mesh, and two end portions, one end portion extending in each direction from the central support portion.
  • Other implants can include a support portion having larger dimensions relative to the extension portions, with multiple (e.g., two or four) elongate extension portions extending from the support portion.
  • a size and shape of an implant support portion can be for use to contact and support vaginal tissue, nearby bladder tissue, or both, to treat prolapse, specifically anterior defects, lateral defects, and cystocele.
  • These exemplary implants may be useful in the TARS and TAWS procedures.
  • a support portion may be sized to contact and support a bladder superior to prolapsed vaginal tissue.
  • a support portion may be designed to act as support for the bladder, as a replacement to, or reinforcement of, the hammock-type tissue that naturally supports the bladder, including pubocervical fascia.
  • the support portion can be placed to contact bladder tissue and tissue supportive of the bladder, including pubocervical fascia.
  • the support portion can be attached to the bladder support tissue (e.g., pubocervical fascia) and may extend to be near (within 1 centimeter from) or in contact with the arcus tendineus.
  • Such embodiments of support portions can include curved or circular edges and may be circular in shape (meaning circular, oblong, oval, or approximately circular with multiple obtuse angles).
  • Alternate support portions may be square, rectangular, or rectangular with rounded ends, such as rectangular with rounded anterior and posterior ends.
  • a support portion may be of a size to extend from one lateral side of a pelvic region, below a bladder, and across to the other lateral side of the pelvic region, e.g., from near or in contact with one arcus tendineus, across the pelvic region and below a bladder, to a position that is near or in contact with an opposing arcus tendineus.
  • the mesh support portion can form new support tissue for the bladder (e.g., a hammock) over which the bladder is suspended.
  • implant embodiments can include a support portion that can be connected to lateral vaginal tissue (vaginal sulcus) on one side of a vagina.
  • lateral vaginal tissue vaginal sulcus
  • Two of these implants can be used in combination, one being implanted on each of a left side and a right side of a vagina, to support both a lateral left side and a lateral right side tissue of a vagina, to treat paravaginal, lateral, and anterior defects and cystocele.
  • a support portion can be in the form of an elongate strip having a length in the range from about 4 to about 5 centimeters and width in the range from about 0.5 to about 1.3 centimeters.
  • an implant can include one or more appurtenant features including a tensioning device (or “tensioning member”) such as a suture or a sheath, and a connector or a dilating connector (e.g., “dilator,” suture, or the like) that removably or securely (e.g., permanently) engages a tip of a needle of an implantation tool.
  • a tensioning device or “tensioning member”
  • tensioning member such as a suture or a sheath
  • a connector or a dilating connector e.g., “dilator,” suture, or the like
  • an implant may be a one piece mesh strip with the support portion substantially continuous with (i.e., integral with) end portions, also optionally including a plastic sheath enclosing the mesh strip, an optional tensioning suture running along all or a portion of the length of the mesh strip, and one or two connectors, sutures, or dilators, one at the end of each extension portion.
  • a further feature can be one or more sutures or other attachment mechanisms located and attached at an end of the implant or along a length of the implant, for example extending from a support portion or an extension portion.
  • An implant can be placed within a tissue path by assistance of an insertion tool.
  • insertions tool that include an elongate needle useful to prepare one or more of the tissue paths described herein, include those described at United States Patent Applications 2005/0245787 (Ser. No. 10/834,943), 2007/0068538 (Ser. No. 11/518,932), 2005/0143618 (Ser. No. 11/064,875), and 2009-0023978 (Ser. No. 12/229,655), the entireties of these documents being incorporated herein by reference.
  • Such tools generally include a handle and an elongate needle portion that is curved in two or three dimensions.
  • the needle can be used to create a tissue path extending from an external incision to a region of vaginal tissue near a vaginal (e.g., mid-line) incision, and also to pull or push an implant or a portion thereof (e.g., extension portion) through the tissue path.
  • embodiments of these implant can have varied shapes and configurations.
  • each there can be a central portion (or “support portion”) capable of supporting an anatomical structure such as the bladder.
  • a number of arms (or “extension portions”) useful to secure the implant in a patient can extend away from the support portion.
  • FIG. 1A this illustration shows a pelvic region including pelvic bone, pubic symphasis 20 , right and left obturator foramen 24 , bladder 22 , and obturator vessels and nerves 26 .
  • Implant 10 includes mesh support portion 14 positioned above a vagina (not shown) to support the bladder. The implant can be positioned in a manner to support bladder 22 and treat cystocele, e.g., due to a lateral, e.g., paravaginal defect.
  • the positioning can include placing support portion 14 below bladder 22 , optionally with edges 13 located near or in contact with tissue of opposing arcus tendineus (not shown), e.g., each edge 13 can be located within 1 centimeter of a right or left arcus tendineus, or in contact with the arcus tendineus.
  • each extension portion 12 extends within a tissue path leading from a region of the vaginal tissue to an obturator foramen.
  • Tro extension portions 12 are shown in implanted positions through an obturator foramen, and two others are shown partially implanted.
  • Two superior (anterior) arms can be placed at or just below the bladder neck and extend to a superior incision.
  • Two inferior (posterior) arms can be placed 1.5 centimeters proximal to the ischial spine.
  • Each extension portion can be extended through an obturator foramen at a separate incision, one superior and one inferior, and then continue further through an external incision (not shown), including one superior external incision and one inferior external incision per side of the patient.
  • An example of a superior external incision may be placed approximately 0.5 centimeters medial to a geniot crural fold at the level of the clitoris below an adductor longus tendon.
  • An example of an inferior external incision may be placed approximately 2 centimeters lateral to and 3 centimeters below the superior incision; this point should correspond to the lowermost portion of the obturator membrane directly above the ischial tuberosity—if by palpation this point is askew then the palpatory point can be used for precise incision inferiorly.
  • FIG. 1B shows a specific design of a mesh implant useful according to the TARS embodiment, e.g., as illustrated at FIG. 1A .
  • Implant 30 includes rectangular or square support portion 32 and four elongate extension portions 34 , each extending away from a corner of support portion 32 .
  • Length dimension L 2 the length of the total implant including support portion 32 and two opposing extension portions 34 , may be from 15 to 20 centimeters.
  • Lengths L 1 of each extension portion 34 may be, e.g., from 4 to 6 centimeters.
  • Width W 2 of support portion 32 can be, e.g., from 3 to 6 centimeters.
  • Width W 1 of each extension portion 32 can be from 0.5 to 1.3 centimeter.
  • FIG. 1C shows another specific design of a mesh implant useful according to the TARS embodiment, e.g., as illustrated at FIG. 1A .
  • Implant 40 includes support portion 42 and four elongate extension portions 44 , each extending away from a corner of support portion 42 .
  • Support portion 42 is rectangular with rounded anterior and posterior ends.
  • Length dimension L 4 may be from 15 to 20 centimeters.
  • Lengths L 3 of each extension portion 44 may be, e.g., from 4 to 6 centimeters.
  • Width W 4 of support portion 42 including the two rounded ends can be, e.g., from 3 to 8 centimeters.
  • Width W 3 of each extension portion 4 can be from 0.5 to 1.3 centimeter.
  • FIG. 1D shows another specific design of a mesh implant useful according to the TARS embodiment, e.g., as illustrated at FIG. 1A .
  • Implant 45 includes support portion 46 and four elongate extension portions 48 . Each extension portion extends away from an edge (e.g., corner) of support portion 46 in a direction perpendicular to the edge of the circular support portion. Alternately, other angles may be useful; for example extension portions 48 of implant 45 may be arranged similarly to extension portions 44 of implant 40 , sets of extension portions extending from the support portion in parallel and opposing directions.
  • Support portion 46 is circular and may be oval or oblong. Length dimension L 5 may be from 15 to 20 centimeters.
  • Lengths L 6 of each extension portion 48 may be, e.g., from 4 to 6 centimeters.
  • Width (diameter) W 6 of support portion 46 can be, e.g., from 3 to 8 centimeters.
  • Width W 5 of each extension portion 48 can be from 0.5 to 1.3 centimeter.
  • FIG. 1E shows another specific design of a mesh implant useful according to the TARS embodiment, e.g., as illustrated at FIG. 1A .
  • Implant 49 includes support portion 50 and two elongate extension portions 52 . Each extension portion extends away from an edge of support portion 50 in a direction perpendicular to the edge, and opposite and parallel with the opposing extension portion.
  • Support portion 50 is square but may be rectangular, trapezoidal, etc.
  • Length dimension L 8 may be from 15 to 20 centimeters.
  • Lengths L 9 of each extension portion 52 may be, e.g., from 4 to 6 centimeters.
  • Width W 7 of support portion 50 can be, e.g., from 3 to 6 centimeters.
  • Length L 9 of support portion 50 can be, e.g., from 3 to 6 centimeters.
  • Width W 8 of each extension portion 52 can be from 0.5 to 1.3 centimeter.
  • each of a pair of implants can be a generally elongate member having a pair of ends, i.e., mesh strips of substantially uniform length and construction.
  • Implants 60 and 62 each include a mesh support portion (P S ) (preferably from 4 to 6 centimeters in length and from 0.5 to 1.3 centimeters wide) and two extension portions (PE), one on either side of the support portion (also preferably from 4 to 6 centimeters in length and from 0.5 to 1.3 centimeters wide).
  • a guide suture or other guide device can be attached to each end of the mesh strip; as illustrated, sutures 64 are attached at each end of implants 60 and 62 .
  • the guide sutures on the ends of the elongate body can be used to pull the elongate member through a tissue path, e.g., by assistance using an insertion tool, optionally a two dimensional or a helical insertion tool.
  • guide sutures 64 can be attached to needles, illustrated in FIGS. 3A and 3B , which can be used to guide and pull the elongate member through the patient's tissue.
  • placement sutures or anchors can be disposed on a portion of the elongate member between its ends, along its length.
  • three placement sutures 66 are located along the length of the implant and can be used to position or place the elongate member on an anatomical structure such as the vaginal sulcus, e.g., the sutures can be attached to vaginal tissue such as vaginal sulcus tissue.
  • Implant 62 of FIG. 2 includes an optional sheath 68 , covering the support portion, placement sutures 66 , and at least portions of extension portions.
  • the sheath can be a transparent plastic sheath or envelope, for example, that can remain on the sheath during insertion and that can be removed after the position of the implant is adjusted as desired.
  • Implants 60 and 62 can be made from any material such as a mesh material and the placement sutures and guide sutures can be made from any material such as the material used for vicryl sutures.
  • the elongate member can be enclosed by a plastic sheath or envelope that aids in moving the elongate member through a patient's tissue.
  • the sheath or envelope can be made of any material such as plastic or paper, optionally lubricated, and can preferably be a clear flexible plastic.
  • FIG. 4 illustrates a pelvic region including pelvic bone, pubic symphasis 20 , right and left obturator foramen 24 , vaginal sulci 25 , midline incision 27 in vaginal tissue, and obturator vessels and nerves 26 .
  • Each implant 80 is a mesh strip that includes mesh support portion 84 , extension portions 82 , and sutures 86 .
  • Each mesh support portion 84 is attached to lateral vaginal tissue (sulcus) by sutures 86 .
  • Each extension portion 82 extends within a tissue path leading from a region of vaginal tissue to an obturator foramen.
  • each extension portion 82 further extends through the obturator foramen at a separate incision (one incision for each extension portion 82 ), one superior and one inferior, and then continues further through an external incision (not shown), including one superior external incision and one inferior external incision, per side of the patient.
  • insertion tool 70 comprising needle 72 and handle 74 is suitable for use in methods described herein.
  • Handle 72 can be any suitable handle known in the art or otherwise useful.
  • U.S. Pat. No. 6,652,450 hereby incorporated by reference in its entirety, discloses several possible configurations.
  • Needle 72 is generally curved or arcuate, preferably in three dimensions, to form a helix as illustrated.
  • the shape of needle 72 should facilitate and provide controlled passage of needle 74 through tissue as required, e.g., to allow the tip to pass from an external incision at a labia or inner groin region of a patient, through an obturator foramen, and to a region of vaginal tissue.
  • End or tip 76 of needle 72 can be configured to engage an end of an implant, such as a dilator, connector, suture, or mesh piece at an end of an implant.
  • an implant such as a dilator, connector, suture, or mesh piece at an end of an implant.
  • Tip 76 is generally not sharpened but may be tapered to afford easy passage through tissue while providing a blunt surface that avoids cutting sensitive tissue. It is preferred that the diameter of needle 72 be small, to reduce tissue trauma.
  • the patient is placed in a lithotomy position.
  • the physician makes a mid-line vaginal incision and dissects equal to a typical central cystocele repair.
  • External incisions are then made near the obturator foramen, e.g., a superior external incision and an inferior external incision, one on each side of the patient.
  • a two- or three-dimensionally curved needle such as the one illustrated in FIGS. 3A and 3B , an end of the needle can be pushed through an external incision and through the obturator foramen to enter the vagina through the vaginal incision, to meet and engage an extension portion of the implant.
  • Exemplary steps of a method of placing an implant as illustrated at FIG. 1 , for treating a lateral vaginal defect (e.g., paravaginal defect) and related cystocele can include the following features.
  • an implant as described having a support portion and four extension portions.
  • the mesh support portion may extend below the bladder, optionally to opposing arcus tendineus of the patient, either to contact the arcus tendineus or to be within 1 centimeter of the arcus tendineus.
  • the mesh support portion may optionally be attached, e.g., by suture, staple, or other securement mechanism, to tissue such as pubocervical fascia, arcus tendineus, or both.
  • Preparing a tissue path between the superior left external incision and the lateral vaginal tissue on a left side of the vagina e.g., using a helical needle.
  • Preparing a tissue path between the inferior left external incision and the lateral vaginal tissue on a left side of the vagina e.g., using a helical needle.
  • Preparing a tissue path between the superior right external incision and the lateral vaginal tissue on a right side of the vagina e.g., using a helical needle.
  • a physician identifies a defect such as displacement cystocele with paravaginal defect.
  • the physician can then clearly identify the vaginal sulcus and ensure there is sufficient tissue to attach implant material on both sides if necessary.
  • a surgical marker can be used if needed.
  • a mid-line vaginal incision can be made and routine para urethral dissection into the retropubic space is conducted.
  • a digital palpitation of posterior aspect of obturator internus is done.
  • a physician should then palpate on the external skin of vulva where the mesh will pull through in 2 points (e.g., a superior incision and an inferior incision as these are described herein).
  • the mesh (support portion) can then be attached to the vaginal sulcus with the placement sutures. Additional placement sutures can be trimmed or attached if necessary.
  • An external incision can be made near the obturator foreman.
  • a needle such as the one illustrated in FIGS. 3A and 3B , its end can be pushed through the obturator foramen to enter the vagina through the midline incision. Repeat at a posterior-inferior site keeping clear of the obturator vessels.
  • the ends of the needles can be guided using one or more digits of your hand within the retropubic space.
  • the guide sutures can be attached to the needles and the mesh (mesh strip implant) can be pulled through the obturator foramen and external incision. While pulling the mesh placement should be checked on both sides without removing the plastic sheath (if present). Ensure that the midline vaginal incision can be closed without tension. The vaginal incision is then closed and the midline fascia can be repaired if necessary. The implant can then be adjusted. Lastly, the plastic envelope (if present) can be removed and the mesh implant can be trimmed flush with the skin. The mesh implant can be left unsutured or sutured.
  • Exemplary steps of a method of placing a system of implants as illustrated at FIG. 3 , for treating a paravaginal defect and related cystocele can include the following features.

Abstract

A system for treating vaginal prolapse including two implants, each implant including a mesh support portion and two mesh extension portions, wherein for each implant the support portion is capable of contacting vaginal sulcus tissue while the two extension portions extend to tissue of an obturator foramen. The implant may include a mesh strip, with the support portion having a length between 4 and 6 centimeters, with the total length of the mesh strip being between 15 and 20 centimeters, and with the mesh strip being of substantially uniform width in the range from 0.5 to 1.3 centimeters. The implant may include two sutures, with one suture connected at each opposing end of the implant, and/or the implant may include one or multiple sutures connected along a length of the implant.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • The present patent application is a continuation application of U.S. patent Ser. No. 13/614,012, filed Sep. 13, 2012, which is a divisional application of U.S. patent application Ser. No. 12/381,459, filed Mar. 12, 2009, which claims the benefit under 35 U.S.C. §119(e) of U.S. Provisional Patent Application No. 61/036,688, filed on Mar. 14, 2008, the entire disclosures of which are incorporated herein by reference in their entireties.
  • TECHNICAL FIELD
  • The present invention relates to vaginal prolapse repair and more particularly to transvaginal prolapse repair.
  • BACKGROUND
  • Anterior vaginal prolapse repairs have historically had recurrence rates of around thirty percent. This is because traditional surgery uses devitalized tissues and paravaginal defects are very difficult to correct transvaginally. Laparoscopic paravaginal defect correction is technically very difficult and there is no data looking at its efficacy. The use of “mesh” for prolapse repair shows greater efficacy in a randomized trial by Sand et al. but does not address total anterior vaginal reconstruction and certainly not paravaginal defect correction.
  • SUMMARY
  • The invention relates to treatments of vaginal prolapse of the types referred to as anterior vaginal prolapse, cystocele, lateral defects, and paravaginal defects. According to embodiments of the invention, mesh implants are provided and placed in a pelvic region to support vaginal tissue, bladder tissue, or both, either directly or by supporting tissue that would otherwise support the bladder or vaginal tissue.
  • A paravaginal defect is a defect of tissue that supports the bladder in a position superior to the vagina. This type of defect can cause the bladder to fall into the vagina and result in vaginal prolapse, including anterior vaginal prolapse such as cystocele, or a lateral defect. An example of a paravaginal defect is a defect in the hammock-type tissue (e.g., pubocervical fascia) that supports the bladder, such as a tear or detachment of the tissue at a “tree end” of the tissue (e.g., the portion of the fascia away from the vaginal tissue, near the arcus tendineus) rather than a tear in the sheet (midline defect). A specific example of a paravaginal defect can be torn pubocervical fascia along or near an arcus tendineus. The defect may be unilateral or bilateral, either way resulting in a cystocoele. A lateral defect (e.g., paravaginal defect) can allow bladder tissue to become unsupported and contact vaginal tissue, resulting in vaginal prolapse, e.g., anterior vaginal prolapse or cystocele. Implants and methods of the present description can treat such conditions by supporting or replacing one or more of vaginal tissue, bladder tissue, or vaginal support tissue or bladder support tissue (e.g., pubocervical fascia).
  • As used herein, the vaginal sulcus is the lateral depth of vagina in the anterior compartment. The vaginal sulcus is usually between 2 and 5 centimeters deep and increases in depth as the vagina extends in a posterior direction.
  • Advantages of the present invention include reconstructing the arcus tendineus with prolene, thereby giving strength. Another advantage includes providing more anatomical repair. The procedure is a minimally invasive technique when compared with abdominal paravaginal repair.
  • In one aspect, the invention relates to an implantable device useful for treating vaginal prolapse including a paravaginal defect. The device includes a mesh support portion and multiple mesh extension portions, the support portion is capable of supporting a bladder. Each extension portion is capable of extending to tissue of an obturator foramen while the support portion supports the bladder.
  • In another aspect, the invention relates to a system for treating vaginal prolapse. The system includes two implants. Each implant includes a mesh support portion and two mesh extension portions. For each implant the support portion is capable of contacting vaginal sulcus tissue while the two extension portions extend to tissue of an obturator foramen.
  • In another aspect, the invention relates to a method of treating cystocele related to a lateral vaginal defect. The method includes: providing an implant as described herein; making an upper vaginal midline incision; passing the implant through the vaginal incision; placing the mesh support portion in a position superior to vaginal tissue, to support a bladder; making a superior left external incision at an inner thigh adjacent to a left obturator foramen, preparing a tissue path between the superior left external incision and the lateral vaginal tissue on a left side of the vagina, passing an extension portion through the tissue path between the superior left external incision and the lateral vaginal tissue on the left side of the vagina; making an inferior left external incision at an inner thigh adjacent to a left obturator foramen, preparing a tissue path between the inferior left external incision and the lateral vaginal tissue on a left side of the vagina, passing an extension portion through the tissue path between the inferior left external incision and the lateral vaginal tissue on the left side of the vagina; making a superior right external incision at an inner thigh adjacent to a right obturator foramen, preparing a tissue path between the superior right external incision and the lateral vaginal tissue on a right side of the vagina, passing an extension portion through the tissue path between the superior right external incision and the lateral vaginal tissue on the right side of the vagina; making an inferior right external incision at an inner thigh adjacent to a right obturator foramen, preparing a tissue path between the inferior right external incision and the lateral vaginal tissue on a right side of the vagina, and passing an extension portion through the tissue path between the inferior right external incision and the lateral vaginal tissue on the right side of the vagina.
  • In another aspect, the invention relates to a method of treating cystocele, including treating a lateral vaginal defect. The method includes: providing a system of implants as described; making an upper vaginal midline incision; passing a first implant of the system through the vaginal incision; placing a mesh support portion of the first implant in contact with lateral vaginal tissue on a left side of the vagina; making a superior left external incision at an inner thigh adjacent to a left obturator foramen, preparing a tissue path between the superior left external incision and the lateral vaginal tissue on a left side of the vagina, passing a first extension portion of the first implant through the tissue path between the superior left external incision and the lateral vaginal tissue on the left side of the vagina; making an inferior left external incision at an inner thigh adjacent to a left obturator foramen, preparing a tissue path between the inferior left external incision and the lateral vaginal tissue on a left side of the vagina, passing a second extension portion of the first implant through the tissue path between the inferior left external incision and the lateral vaginal tissue on the left side of the vagina; passing a second implant through the vaginal incision; placing a mesh support portion of the second implant in contact with lateral vaginal tissue on a right side of the vagina; making a superior right external incision at an inner thigh adjacent to a right obturator foramen, preparing a tissue path between the superior right external incision and the lateral vaginal tissue on a right side of the vagina, passing a first extension portion of the second implant through the tissue path between the superior right external incision and the lateral vaginal tissue on the right side of the vagina; making an inferior right external incision at an inner thigh adjacent to a right obturator foramen, preparing a tissue path between the inferior right external incision and the lateral vaginal tissue on a right side of the vagina, and passing a second extension portion of the second implant through the tissue path between the inferior right external incision and the lateral vaginal tissue on the right side of the vagina.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1A is a perspective view of an embodiment of an implant as described, at least partially implanted in an illustrated pelvis.
  • FIGS. 1B-1E are various configurations of implants as described.
  • FIG. 2 illustrates a system or kit as described, including two implants.
  • FIGS. 3A and 3B illustrate examples of needles useful according to methods described herein.
  • FIG. 4 is a perspective view of an embodiment of a system of implants as described.
  • DETAILED DESCRIPTION
  • The inventive concept utilizes the transobturator approach (used successfully by AMS for suburethral slings) and has two designs concepts. One design or embodiment is the TARS or TAWS (Total anterior vaginal reconstruction system, or Total Anterior Wall Shelf) (see FIG. 1A). The other design or embodiment is the PARS (Para vaginal Anterior vaginal reconstruction) see FIG. 4.
  • An implant can generally include a support portion that contacts tissue to be supported, and two or more opposing extension portions that extend away from the support portion. The terms “support portion” and “extension portion” can be used specifically or generally to denote precise or general portions of an implant. When an implant has a uniform shape from end to end, as does a simple mesh strip, the end portions will not necessarily exhibit a distinct boundary relative to the support portion.
  • Exemplary implants may be in the form of a continuous mesh tape that includes a support portion located at the center of the mesh, and two end portions, one end portion extending in each direction from the central support portion. Other implants can include a support portion having larger dimensions relative to the extension portions, with multiple (e.g., two or four) elongate extension portions extending from the support portion.
  • In one embodiment, a size and shape of an implant support portion can be for use to contact and support vaginal tissue, nearby bladder tissue, or both, to treat prolapse, specifically anterior defects, lateral defects, and cystocele. These exemplary implants may be useful in the TARS and TAWS procedures. For example, a support portion may be sized to contact and support a bladder superior to prolapsed vaginal tissue. Functionally, such a support portion may be designed to act as support for the bladder, as a replacement to, or reinforcement of, the hammock-type tissue that naturally supports the bladder, including pubocervical fascia. The support portion can be placed to contact bladder tissue and tissue supportive of the bladder, including pubocervical fascia. The support portion can be attached to the bladder support tissue (e.g., pubocervical fascia) and may extend to be near (within 1 centimeter from) or in contact with the arcus tendineus. Such embodiments of support portions can include curved or circular edges and may be circular in shape (meaning circular, oblong, oval, or approximately circular with multiple obtuse angles). Alternate support portions may be square, rectangular, or rectangular with rounded ends, such as rectangular with rounded anterior and posterior ends. A support portion may be of a size to extend from one lateral side of a pelvic region, below a bladder, and across to the other lateral side of the pelvic region, e.g., from near or in contact with one arcus tendineus, across the pelvic region and below a bladder, to a position that is near or in contact with an opposing arcus tendineus. The mesh support portion can form new support tissue for the bladder (e.g., a hammock) over which the bladder is suspended.
  • Other implant embodiments, e.g., useful in the PARS and PAWS embodiments, can include a support portion that can be connected to lateral vaginal tissue (vaginal sulcus) on one side of a vagina. Two of these implants can be used in combination, one being implanted on each of a left side and a right side of a vagina, to support both a lateral left side and a lateral right side tissue of a vagina, to treat paravaginal, lateral, and anterior defects and cystocele. For example, such a support portion can be in the form of an elongate strip having a length in the range from about 4 to about 5 centimeters and width in the range from about 0.5 to about 1.3 centimeters.
  • Optionally and preferably an implant can include one or more appurtenant features including a tensioning device (or “tensioning member”) such as a suture or a sheath, and a connector or a dilating connector (e.g., “dilator,” suture, or the like) that removably or securely (e.g., permanently) engages a tip of a needle of an implantation tool.
  • In various embodiments an implant may be a one piece mesh strip with the support portion substantially continuous with (i.e., integral with) end portions, also optionally including a plastic sheath enclosing the mesh strip, an optional tensioning suture running along all or a portion of the length of the mesh strip, and one or two connectors, sutures, or dilators, one at the end of each extension portion. Yet a further feature can be one or more sutures or other attachment mechanisms located and attached at an end of the implant or along a length of the implant, for example extending from a support portion or an extension portion.
  • An implant can be placed within a tissue path by assistance of an insertion tool. Examples of insertions tool that include an elongate needle useful to prepare one or more of the tissue paths described herein, include those described at United States Patent Applications 2005/0245787 (Ser. No. 10/834,943), 2007/0068538 (Ser. No. 11/518,932), 2005/0143618 (Ser. No. 11/064,875), and 2009-0023978 (Ser. No. 12/229,655), the entireties of these documents being incorporated herein by reference. Such tools generally include a handle and an elongate needle portion that is curved in two or three dimensions. The needle can be used to create a tissue path extending from an external incision to a region of vaginal tissue near a vaginal (e.g., mid-line) incision, and also to pull or push an implant or a portion thereof (e.g., extension portion) through the tissue path.
  • Referring to the example embodiment of TARS and TAWS illustrated at FIGS. 1A through 1E, embodiments of these implant can have varied shapes and configurations. In at least one embodiment of each there can be a central portion (or “support portion”) capable of supporting an anatomical structure such as the bladder. A number of arms (or “extension portions”) useful to secure the implant in a patient can extend away from the support portion.
  • Referring specifically to FIG. 1A, this illustration shows a pelvic region including pelvic bone, pubic symphasis 20, right and left obturator foramen 24, bladder 22, and obturator vessels and nerves 26. Implant 10 includes mesh support portion 14 positioned above a vagina (not shown) to support the bladder. The implant can be positioned in a manner to support bladder 22 and treat cystocele, e.g., due to a lateral, e.g., paravaginal defect. The positioning can include placing support portion 14 below bladder 22, optionally with edges 13 located near or in contact with tissue of opposing arcus tendineus (not shown), e.g., each edge 13 can be located within 1 centimeter of a right or left arcus tendineus, or in contact with the arcus tendineus.
  • Still referring to FIG. 1, four longitudinal extension portions 12 extend away from support portion 14. Each extension portion 12 extends within a tissue path leading from a region of the vaginal tissue to an obturator foramen. (Two extension portions 12 are shown in implanted positions through an obturator foramen, and two others are shown partially implanted.) Two superior (anterior) arms (alternately considered, an anterior segment or edge of the support portion) can be placed at or just below the bladder neck and extend to a superior incision. Two inferior (posterior) arms (alternately considered, a posterior segment or edge of the support portion) can be placed 1.5 centimeters proximal to the ischial spine. Each extension portion can be extended through an obturator foramen at a separate incision, one superior and one inferior, and then continue further through an external incision (not shown), including one superior external incision and one inferior external incision per side of the patient. An example of a superior external incision may be placed approximately 0.5 centimeters medial to a geniot crural fold at the level of the clitoris below an adductor longus tendon. An example of an inferior external incision may be placed approximately 2 centimeters lateral to and 3 centimeters below the superior incision; this point should correspond to the lowermost portion of the obturator membrane directly above the ischial tuberosity—if by palpation this point is askew then the palpatory point can be used for precise incision inferiorly.
  • FIG. 1B shows a specific design of a mesh implant useful according to the TARS embodiment, e.g., as illustrated at FIG. 1A. Implant 30 includes rectangular or square support portion 32 and four elongate extension portions 34, each extending away from a corner of support portion 32. Length dimension L2, the length of the total implant including support portion 32 and two opposing extension portions 34, may be from 15 to 20 centimeters. Lengths L1 of each extension portion 34 may be, e.g., from 4 to 6 centimeters. Width W2 of support portion 32 can be, e.g., from 3 to 6 centimeters. Width W1 of each extension portion 32 can be from 0.5 to 1.3 centimeter.
  • FIG. 1C shows another specific design of a mesh implant useful according to the TARS embodiment, e.g., as illustrated at FIG. 1A. Implant 40 includes support portion 42 and four elongate extension portions 44, each extending away from a corner of support portion 42. Support portion 42 is rectangular with rounded anterior and posterior ends. Length dimension L4 may be from 15 to 20 centimeters. Lengths L3 of each extension portion 44 may be, e.g., from 4 to 6 centimeters. Width W4 of support portion 42, including the two rounded ends can be, e.g., from 3 to 8 centimeters. Width W3 of each extension portion 4 can be from 0.5 to 1.3 centimeter.
  • FIG. 1D shows another specific design of a mesh implant useful according to the TARS embodiment, e.g., as illustrated at FIG. 1A. Implant 45 includes support portion 46 and four elongate extension portions 48. Each extension portion extends away from an edge (e.g., corner) of support portion 46 in a direction perpendicular to the edge of the circular support portion. Alternately, other angles may be useful; for example extension portions 48 of implant 45 may be arranged similarly to extension portions 44 of implant 40, sets of extension portions extending from the support portion in parallel and opposing directions. Support portion 46 is circular and may be oval or oblong. Length dimension L5 may be from 15 to 20 centimeters. Lengths L6 of each extension portion 48 may be, e.g., from 4 to 6 centimeters. Width (diameter) W6 of support portion 46 can be, e.g., from 3 to 8 centimeters. Width W5 of each extension portion 48 can be from 0.5 to 1.3 centimeter.
  • FIG. 1E shows another specific design of a mesh implant useful according to the TARS embodiment, e.g., as illustrated at FIG. 1A. Implant 49 includes support portion 50 and two elongate extension portions 52. Each extension portion extends away from an edge of support portion 50 in a direction perpendicular to the edge, and opposite and parallel with the opposing extension portion. Support portion 50 is square but may be rectangular, trapezoidal, etc. Length dimension L8 may be from 15 to 20 centimeters. Lengths L9 of each extension portion 52 may be, e.g., from 4 to 6 centimeters. Width W7 of support portion 50 can be, e.g., from 3 to 6 centimeters. Length L9 of support portion 50 can be, e.g., from 3 to 6 centimeters. Width W8 of each extension portion 52 can be from 0.5 to 1.3 centimeter.
  • Referring to an embodiment of a system of implants useful in the PARS method, illustrated in FIG. 2, each of a pair of implants can be a generally elongate member having a pair of ends, i.e., mesh strips of substantially uniform length and construction. Implants 60 and 62 each include a mesh support portion (PS) (preferably from 4 to 6 centimeters in length and from 0.5 to 1.3 centimeters wide) and two extension portions (PE), one on either side of the support portion (also preferably from 4 to 6 centimeters in length and from 0.5 to 1.3 centimeters wide). A guide suture or other guide device can be attached to each end of the mesh strip; as illustrated, sutures 64 are attached at each end of implants 60 and 62. The guide sutures on the ends of the elongate body can be used to pull the elongate member through a tissue path, e.g., by assistance using an insertion tool, optionally a two dimensional or a helical insertion tool. For example guide sutures 64 can be attached to needles, illustrated in FIGS. 3A and 3B, which can be used to guide and pull the elongate member through the patient's tissue.
  • As particularly illustrated in FIG. 2, placement sutures or anchors can be disposed on a portion of the elongate member between its ends, along its length. As illustrated, three placement sutures 66 are located along the length of the implant and can be used to position or place the elongate member on an anatomical structure such as the vaginal sulcus, e.g., the sutures can be attached to vaginal tissue such as vaginal sulcus tissue.
  • Implant 62 of FIG. 2 includes an optional sheath 68, covering the support portion, placement sutures 66, and at least portions of extension portions. The sheath can be a transparent plastic sheath or envelope, for example, that can remain on the sheath during insertion and that can be removed after the position of the implant is adjusted as desired.
  • Implants 60 and 62 can be made from any material such as a mesh material and the placement sutures and guide sutures can be made from any material such as the material used for vicryl sutures. As illustrated in FIG. 2, the elongate member can be enclosed by a plastic sheath or envelope that aids in moving the elongate member through a patient's tissue. The sheath or envelope can be made of any material such as plastic or paper, optionally lubricated, and can preferably be a clear flexible plastic.
  • FIG. 4 illustrates a pelvic region including pelvic bone, pubic symphasis 20, right and left obturator foramen 24, vaginal sulci 25, midline incision 27 in vaginal tissue, and obturator vessels and nerves 26. Each implant 80 is a mesh strip that includes mesh support portion 84, extension portions 82, and sutures 86. Each mesh support portion 84 is attached to lateral vaginal tissue (sulcus) by sutures 86. Each extension portion 82 extends within a tissue path leading from a region of vaginal tissue to an obturator foramen. As illustrated, each extension portion 82 further extends through the obturator foramen at a separate incision (one incision for each extension portion 82), one superior and one inferior, and then continues further through an external incision (not shown), including one superior external incision and one inferior external incision, per side of the patient.
  • Referring to FIGS. 3A and 3B, insertion tool 70 comprising needle 72 and handle 74 is suitable for use in methods described herein. Handle 72 can be any suitable handle known in the art or otherwise useful. U.S. Pat. No. 6,652,450, hereby incorporated by reference in its entirety, discloses several possible configurations. Needle 72 is generally curved or arcuate, preferably in three dimensions, to form a helix as illustrated. The shape of needle 72 should facilitate and provide controlled passage of needle 74 through tissue as required, e.g., to allow the tip to pass from an external incision at a labia or inner groin region of a patient, through an obturator foramen, and to a region of vaginal tissue.
  • End or tip 76 of needle 72 can be configured to engage an end of an implant, such as a dilator, connector, suture, or mesh piece at an end of an implant. Many different configurations of such a system are known and within the scope of the present invention. Several are disclosed in U.S. Pat. No. 6,652,450, which is incorporated by reference, as well as other patent documents identified herein. Tip 76 is generally not sharpened but may be tapered to afford easy passage through tissue while providing a blunt surface that avoids cutting sensitive tissue. It is preferred that the diameter of needle 72 be small, to reduce tissue trauma.
  • To perform a TARS or TAWS placement, the patient is placed in a lithotomy position. The physician makes a mid-line vaginal incision and dissects equal to a typical central cystocele repair. External incisions are then made near the obturator foramen, e.g., a superior external incision and an inferior external incision, one on each side of the patient. Using a two- or three-dimensionally curved needle, such as the one illustrated in FIGS. 3A and 3B, an end of the needle can be pushed through an external incision and through the obturator foramen to enter the vagina through the vaginal incision, to meet and engage an extension portion of the implant. A second needle (two-dimensionally or three-dimensionally curved) can be used in a second incision through the obturator foramen. One of the needles can enter into a lower ⅓ of the vagina and the other needle can enter into a mid portion of the vagina. The arms (extension portions) of the implant can be attached to the needles, which can be withdrawn through the obturator foramen. Anterior (superior) extension portions or an anterior edge or portion of the implant can be placed under the base of the bladder or 1 cm inferior to the base of the bladder or just below the bladder neck. Inferior (posterior) extension portions or a posterior edge or portion of the implant can be placed at the vagina approximately 1 centimeter proximal to the ischial spine.
  • Exemplary steps of a method of placing an implant as illustrated at FIG. 1, for treating a lateral vaginal defect (e.g., paravaginal defect) and related cystocele, can include the following features.
  • Providing an implant as described, having a support portion and four extension portions.
  • Making an upper vaginal midline incision.
  • Passing the implant through the vaginal incision.
  • Placing the mesh support portion in a position superior to vaginal tissue, to support a bladder. The mesh support portion may extend below the bladder, optionally to opposing arcus tendineus of the patient, either to contact the arcus tendineus or to be within 1 centimeter of the arcus tendineus. The mesh support portion may optionally be attached, e.g., by suture, staple, or other securement mechanism, to tissue such as pubocervical fascia, arcus tendineus, or both.
  • Making a superior left external incision at an inner thigh adjacent to a left obturator foramen.
  • Preparing a tissue path between the superior left external incision and the lateral vaginal tissue on a left side of the vagina, e.g., using a helical needle.
  • Passing an extension portion through the tissue path between the superior left external incision and the lateral vaginal tissue on the left side of the vagina.
  • Making an inferior left external incision at an inner thigh adjacent to a left obturator foramen.
  • Preparing a tissue path between the inferior left external incision and the lateral vaginal tissue on a left side of the vagina, e.g., using a helical needle.
  • Passing an extension portion through the tissue path between the inferior left external incision and the lateral vaginal tissue on the left side of the vagina.
  • Making a superior right external incision at an inner thigh adjacent to a right obturator foramen.
  • Preparing a tissue path between the superior right external incision and the lateral vaginal tissue on a right side of the vagina, e.g., using a helical needle.
  • Passing an extension portion through the tissue path between the superior right external incision and the lateral vaginal tissue on the right side of the vagina.
  • Making an inferior right external incision at an inner thigh adjacent to a right obturator foramen, Preparing a tissue path between the inferior right external incision and the lateral vaginal tissue on a right side of the vagina, e.g., using a helical needle.
  • And passing an extension portion through the tissue path between the inferior right external incision and the lateral vaginal tissue on the right side of the vagina.
  • To perform a PARS placement, a physician identifies a defect such as displacement cystocele with paravaginal defect. The physician can then clearly identify the vaginal sulcus and ensure there is sufficient tissue to attach implant material on both sides if necessary. A surgical marker can be used if needed. A mid-line vaginal incision can be made and routine para urethral dissection into the retropubic space is conducted. Next, a digital palpitation of posterior aspect of obturator internus is done. A physician should then palpate on the external skin of vulva where the mesh will pull through in 2 points (e.g., a superior incision and an inferior incision as these are described herein). The mesh (support portion) can then be attached to the vaginal sulcus with the placement sutures. Additional placement sutures can be trimmed or attached if necessary.
  • An external incision can be made near the obturator foreman. Using a needle such as the one illustrated in FIGS. 3A and 3B, its end can be pushed through the obturator foramen to enter the vagina through the midline incision. Repeat at a posterior-inferior site keeping clear of the obturator vessels. To ensure proper placement, the ends of the needles can be guided using one or more digits of your hand within the retropubic space.
  • In one embodiment, the guide sutures can be attached to the needles and the mesh (mesh strip implant) can be pulled through the obturator foramen and external incision. While pulling the mesh placement should be checked on both sides without removing the plastic sheath (if present). Ensure that the midline vaginal incision can be closed without tension. The vaginal incision is then closed and the midline fascia can be repaired if necessary. The implant can then be adjusted. Lastly, the plastic envelope (if present) can be removed and the mesh implant can be trimmed flush with the skin. The mesh implant can be left unsutured or sutured.
  • Exemplary steps of a method of placing a system of implants as illustrated at FIG. 3, for treating a paravaginal defect and related cystocele, can include the following features.
  • Providing a system of implants as described herein, e.g., as illustrated at FIG. 3.
  • Making an upper vaginal midline incision.
  • Passing a first implant through the vaginal incision.
  • Placing a mesh support portion of the first implant in contact with lateral vaginal tissue (sulcus) on a left side of the vagina.
  • Making a superior left external incision at an inner thigh adjacent to a left obturator foramen.
  • Preparing a tissue path between the superior left external incision and the lateral vaginal tissue (sulcus) on a left side of the vagina,
  • Passing a superior extension portion of the first implant through the tissue path between the superior left external incision and the lateral vaginal tissue on the left side of the vagina.
  • Making an inferior left external incision at an inner thigh adjacent to a left obturator foramen.
  • Preparing a tissue path between the inferior left external incision and the lateral vaginal tissue on a left side of the vagina,
  • Passing an inferior extension portion of the first implant through the tissue path between the inferior left external incision and the lateral vaginal tissue on the left side of the vagina.
  • Passing a second implant through the vaginal incision.
  • Placing a mesh support portion of the second implant in contact with lateral vaginal tissue (sulcus) on a right side of the vagina.
  • Making a superior right external incision at an inner thigh adjacent to a right obturator foramen.
  • Preparing a tissue path between the superior right external incision and the lateral vaginal tissue on a right side of the vagina.
  • Passing a superior extension portion of the second implant through the tissue path between the superior right external incision and the lateral vaginal tissue on the right side of the vagina.
  • Making an inferior right external incision at an inner thigh adjacent to a right obturator foramen.
  • Preparing a tissue path between the inferior right external incision and the lateral vaginal tissue on a right side of the vagina.
  • And passing an inferior extension portion of the second implant through the tissue path between the inferior right external incision and the lateral vaginal tissue on the right side of the vagina.

Claims (5)

1. An implant system for treating vaginal prolapse using a paravaginal anterior vaginal reconstruction technique, the implant system comprising:
a first support portion attachable to vaginal sulcus tissue on a left side of a vagina, and first and second extension portions extending from opposite ends of the first support portion, wherein the first and second extension portions are extendable to the tissue of a left obturator foramen when the first support portion is attached to vaginal sulcus tissue; and
a second support portion attachable to vaginal sulcus tissue on a right side of the vagina, and third and fourth extension portions extending from opposite ends of the second support portion, wherein the third and fourth extension portions are extendable to the tissue of a right obturator foramen when the second support portion is attached to vaginal sulcus tissue.
2. The implant system of claim 1, wherein each of the first and second extension portions comprises a distal end from which a guide suture extends
3. The implant system of claim 2, wherein each of the guide sutures is engageable with a helical insertion tool.
4. The implant system of claim 1, wherein the first support portion comprises multiple placement sutures located between its ends along at least a portion of its length, wherein the placement sutures are attachable to vaginal sulcus tissue.
5. The implant system of claim 1, further comprising a removable sheath that covers the first support portion and at least portions of the first and second extension portions.
US14/867,593 2008-03-14 2015-09-28 Apparatus and method for repairing vaginal reconstruction Abandoned US20160015504A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/867,593 US20160015504A1 (en) 2008-03-14 2015-09-28 Apparatus and method for repairing vaginal reconstruction

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3668808P 2008-03-14 2008-03-14
US12/381,459 US20090240102A1 (en) 2008-03-14 2009-03-12 Apparatus and method for repairing vaginal reconstruction
US13/614,012 US9149351B2 (en) 2008-03-14 2012-09-13 Apparatus and method for repairing vaginal reconstruction
US14/867,593 US20160015504A1 (en) 2008-03-14 2015-09-28 Apparatus and method for repairing vaginal reconstruction

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/614,012 Continuation US9149351B2 (en) 2008-03-14 2012-09-13 Apparatus and method for repairing vaginal reconstruction

Publications (1)

Publication Number Publication Date
US20160015504A1 true US20160015504A1 (en) 2016-01-21

Family

ID=41089585

Family Applications (3)

Application Number Title Priority Date Filing Date
US12/381,459 Abandoned US20090240102A1 (en) 2008-03-14 2009-03-12 Apparatus and method for repairing vaginal reconstruction
US13/614,012 Active 2029-11-24 US9149351B2 (en) 2008-03-14 2012-09-13 Apparatus and method for repairing vaginal reconstruction
US14/867,593 Abandoned US20160015504A1 (en) 2008-03-14 2015-09-28 Apparatus and method for repairing vaginal reconstruction

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US12/381,459 Abandoned US20090240102A1 (en) 2008-03-14 2009-03-12 Apparatus and method for repairing vaginal reconstruction
US13/614,012 Active 2029-11-24 US9149351B2 (en) 2008-03-14 2012-09-13 Apparatus and method for repairing vaginal reconstruction

Country Status (2)

Country Link
US (3) US20090240102A1 (en)
AU (1) AU2009200974B2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6641525B2 (en) 2001-01-23 2003-11-04 Ams Research Corporation Sling assembly with secure and convenient attachment
US8109866B2 (en) * 2005-04-26 2012-02-07 Ams Research Corporation Method and apparatus for prolapse repair
EP2029048A2 (en) 2006-06-16 2009-03-04 AMS Research Corporation Surgical implants and tools for treating pelvic conditions
CA2654294C (en) 2006-06-22 2016-09-20 Ams Research Corporation Adjustable tension incontinence sling assemblies
ATE530142T1 (en) * 2006-07-25 2011-11-15 Ams Res Corp SURGICAL ARTICLES FOR THE TREATMENT OF PELVIC DISEASES
CA2667193C (en) * 2006-10-26 2016-02-16 Ams Research Corporation Surgical articles and methods for treating pelvic conditions
BRPI0814102A2 (en) 2007-07-27 2015-02-03 Ams Res Corp PELVIC IMPLANT, AND, KIT.
US20100298630A1 (en) * 2007-12-07 2010-11-25 Shawn Michael Wignall Pelvic floor treatments and related tools and implants
US9414902B2 (en) * 2009-11-04 2016-08-16 Boston Scientific Scimed, Inc. Method for treating prolapse and incontinence
US9125717B2 (en) 2011-02-23 2015-09-08 Ams Research Corporation Implant tension adjustment system and method
US20130006049A1 (en) 2011-06-30 2013-01-03 Alexander James A Implants, tools, and methods for treatments of pelvic conditions
USD736382S1 (en) 2011-09-08 2015-08-11 Ams Research Corporation Surgical indicator with backers
USD721807S1 (en) 2011-09-08 2015-01-27 Ams Research Corporation Surgical indicators
USD721175S1 (en) 2011-09-08 2015-01-13 Ams Research Corporation Backers for surgical indicators
US10039627B2 (en) 2013-03-11 2018-08-07 Boston Scientific Scimed, Inc. Medical device and method of delivering the medical device
US9757221B2 (en) 2013-09-16 2017-09-12 Boston Scientific Scimed, Inc. Medical device and method of making the same
CN105012048B (en) * 2014-04-18 2018-02-13 林鹤雄 Support the implant of provagina wall prolapsing organ
US10307237B2 (en) * 2015-05-15 2019-06-04 Lifecell Corporation Tissue matrices and methods of treatment
WO2020227095A1 (en) 2019-05-03 2020-11-12 Lifecell Corporation Breast treatment device

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840011A (en) * 1995-11-17 1998-11-24 Ethicon, Inc. Implant for suspension of the urinary bladder in cases of incontinence of urine in women
US20020099259A1 (en) * 2001-01-23 2002-07-25 Anderson Kimberly A. Surgical instrument and method
US20030176762A1 (en) * 2000-03-09 2003-09-18 Kammerer Gene W. Surgical instrument and method for treating organ prolapse conditions
US20060260618A1 (en) * 2005-04-05 2006-11-23 Hodroff Marc A Articles, devices, and methods for pelvic surgery
US20080009665A1 (en) * 2006-02-14 2008-01-10 Caldera Medical, Inc. Implantable Sling For The Treatment Of Incontinence And Method Of Using The Same
US20090171141A1 (en) * 2007-12-27 2009-07-02 Chu Michael S H Anterior Repair - Needle Path and Incision Sites

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172458A (en) * 1977-11-07 1979-10-30 Pereyra Armand J Surgical ligature carrier
GB8611129D0 (en) 1986-05-07 1986-06-11 Annis D Prosthetic materials
US5922026A (en) * 1997-05-01 1999-07-13 Origin Medsystems, Inc. Surgical method and prosthetic strip therefor
CA2304296C (en) 1997-10-01 2005-02-15 Boston Scientific Limited Pelvic floor reconstruction
IT1299162B1 (en) 1998-04-17 2000-02-29 Mauro Cervigni PROSTHETIC ASSEMBLY TO BE USED IN SURGICAL THERAPY OF UROGENITAL PROLAPSE
US6382214B1 (en) * 1998-04-24 2002-05-07 American Medical Systems, Inc. Methods and apparatus for correction of urinary and gynecological pathologies including treatment of male incontinence and female cystocele
FR2785521B1 (en) 1998-11-10 2001-01-05 Sofradim Production SUSPENSION DEVICE FOR THE TREATMENT OF PROLAPSUS AND URINARY INCONTINENCES
US6287316B1 (en) 1999-03-26 2001-09-11 Ethicon, Inc. Knitted surgical mesh
US20050283189A1 (en) * 1999-03-31 2005-12-22 Rosenblatt Peter L Systems and methods for soft tissue reconstruction
FR2792824B1 (en) 1999-04-27 2001-06-22 Sofradim Production DEVICE FOR TREATING PROLAPSUS BY VAGINAL SUSPENSION
EP1060714B1 (en) 1999-06-08 2006-08-02 Ethicon, Inc. Knitted surgical mesh
IT1313574B1 (en) 1999-07-27 2002-09-09 Angiologica B M S R L CORRECTIVE NETWORK FOR BODY FABRICS.
US6306079B1 (en) * 1999-12-07 2001-10-23 Arnaldo F. Trabucco Mesh pubovaginal sling
US6592515B2 (en) * 2000-09-07 2003-07-15 Ams Research Corporation Implantable article and method
US7070556B2 (en) * 2002-03-07 2006-07-04 Ams Research Corporation Transobturator surgical articles and methods
AUPR406501A0 (en) 2001-03-28 2001-04-26 Kaladelfos, George Treatment of vault prolapse
ITMI20011376A1 (en) 2001-06-29 2002-12-29 Siemens Inf & Comm Networks PROCEDURE FOR THE CONTROL OF PACKAGE SWITCHING TRAFFIC IN NUMERICAL MOBILE COMMUNICATION SYSTEMS
US7407480B2 (en) * 2001-07-27 2008-08-05 Ams Research Corporation Method and apparatus for correction of urinary and gynecological pathologies, including treatment of incontinence cystocele
US7087065B2 (en) * 2001-10-04 2006-08-08 Ethicon, Inc. Mesh for pelvic floor repair
IL146534A (en) 2001-11-15 2007-06-17 Gynotech Ltd Adjustable vaginal pessary
BR0308172A (en) 2002-03-01 2005-01-04 Ethicon Inc Method and apparatus for the treatment of pelvic organ prolapse in female patients
KR101001936B1 (en) * 2002-06-07 2010-12-17 후지필름 가부시키가이샤 Dye-containing curable composition, color filter and method of producing the same
ITFI20020145A1 (en) 2002-08-01 2004-02-02 Giulio Nicita DEVICE FOR THE SURGICAL TREATMENT OF FEMALE PROLAXIS.
KR101133460B1 (en) 2002-11-15 2012-04-09 에디컨인코포레이티드 A kit suitable for use in repairing of vagina damaged by pelvic organ prolapse
FR2852817B1 (en) 2003-03-28 2006-04-28 Emmanuel Delorme IMPLANT FOR THE TREATMENT OF THE RECTOCELE AND DEVICE FOR THE PLACEMENT OF THIS IMPLANT
BRPI0408903A (en) * 2003-03-28 2006-03-28 Analytic Biosurgical Solutions implant for treatment of the rectocele and / or vaginal dome prolapse, device for inserting an implant and process for treating the rectocele in a woman
US7494495B2 (en) * 2003-03-28 2009-02-24 Coloplast A/S Method and implant for curing cystocele
ITRM20030210A1 (en) * 2003-04-30 2004-11-01 Mauro Cervigni PROSTHESIS TO BE USED IN THE PROLASSO SURGICAL THERAPY
US7347812B2 (en) * 2003-09-22 2008-03-25 Ams Research Corporation Prolapse repair
US7393319B2 (en) 2003-10-14 2008-07-01 Caldera Medical, Inc. Implantable sling having bladder support
US20050199249A1 (en) * 2004-03-15 2005-09-15 Karram Mickey M. Apparatus and method for incision-free vaginal prolapse repair
WO2005087153A2 (en) 2004-03-18 2005-09-22 Contipi Ltd. Apparatus for the treatment of feminine pelvic organ prolapse
WO2005094741A1 (en) 2004-03-30 2005-10-13 Proxy Biomedical Limited Sling for treatment of urinary stress incontinence and/or pelvic floor prolapse
US7351197B2 (en) * 2004-05-07 2008-04-01 Ams Research Corporation Method and apparatus for cystocele repair
US7500945B2 (en) * 2004-04-30 2009-03-10 Ams Research Corporation Method and apparatus for treating pelvic organ prolapse
GB0411360D0 (en) * 2004-05-21 2004-06-23 Mpathy Medical Devices Ltd Implant
US20050278037A1 (en) * 2004-06-11 2005-12-15 Analytic Biosurgical Solutions-Abiss Implant for the treatment of cystocele and rectocele
ATE553719T1 (en) * 2004-10-05 2012-05-15 Ams Res Corp DEVICE FOR SUPPORTING A VAGINAL CUFF
US7794385B2 (en) * 2004-12-20 2010-09-14 Ams Research Corporation System and method for treatment of anal incontinence and pelvic organ prolapse
CA2878309C (en) * 2005-02-04 2017-11-21 Ams Research Corporation Surgical implants and related methods and systems
WO2006102477A2 (en) * 2005-03-22 2006-09-28 Tyco Healthcare Group, Lp Mesh implant
US8016741B2 (en) 2005-04-06 2011-09-13 Boston Scientific Scimed, Inc. Systems, devices, and methods for sub-urethral support
US7393320B2 (en) * 2005-04-29 2008-07-01 Ams Research Corporation Pelvic floor health articles and procedures
WO2007002071A1 (en) 2005-06-21 2007-01-04 Ams Research Corporation Apparatus for securing a urethral sling to pubic bone
EP3533416A1 (en) 2005-07-25 2019-09-04 Boston Scientific Limited Pelvic floor repair system
WO2007016083A1 (en) 2005-07-26 2007-02-08 Ams Research Corporation Methods and systems for treatment of prolapse
AU2006275350A1 (en) * 2005-08-04 2007-02-08 C.R. Bard, Inc. Pelvic implant systems and methods
WO2007059199A2 (en) 2005-11-14 2007-05-24 C.R. Bard, Inc. Sling anchor system
KR20080108410A (en) 2006-01-10 2008-12-15 앨튼 브이. 홀럼 Levator for repair of perineal prolapse
US9144483B2 (en) * 2006-01-13 2015-09-29 Boston Scientific Scimed, Inc. Placing fixation devices
US8262557B2 (en) 2006-06-08 2012-09-11 Ams Research Corporation Method and apparatus for levator distension repair
EP2029048A2 (en) 2006-06-16 2009-03-04 AMS Research Corporation Surgical implants and tools for treating pelvic conditions
WO2008042434A2 (en) * 2006-10-03 2008-04-10 Boston Scientific Scimed, Inc. Systems and devices for delivering an implant
WO2008124056A1 (en) 2007-04-04 2008-10-16 Ams Research Corporation Kit for levator avulsion repair
BRPI0814102A2 (en) 2007-07-27 2015-02-03 Ams Res Corp PELVIC IMPLANT, AND, KIT.

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840011A (en) * 1995-11-17 1998-11-24 Ethicon, Inc. Implant for suspension of the urinary bladder in cases of incontinence of urine in women
US20030176762A1 (en) * 2000-03-09 2003-09-18 Kammerer Gene W. Surgical instrument and method for treating organ prolapse conditions
US20020099259A1 (en) * 2001-01-23 2002-07-25 Anderson Kimberly A. Surgical instrument and method
US20060260618A1 (en) * 2005-04-05 2006-11-23 Hodroff Marc A Articles, devices, and methods for pelvic surgery
US20080009665A1 (en) * 2006-02-14 2008-01-10 Caldera Medical, Inc. Implantable Sling For The Treatment Of Incontinence And Method Of Using The Same
US20090171141A1 (en) * 2007-12-27 2009-07-02 Chu Michael S H Anterior Repair - Needle Path and Incision Sites

Also Published As

Publication number Publication date
US9149351B2 (en) 2015-10-06
AU2009200974A1 (en) 2009-10-01
US20130006050A1 (en) 2013-01-03
US20090240102A1 (en) 2009-09-24
AU2009200974B2 (en) 2014-06-12

Similar Documents

Publication Publication Date Title
US9149351B2 (en) Apparatus and method for repairing vaginal reconstruction
US10912635B2 (en) Systems and methods for treating a pelvic disorder
US8550980B2 (en) Kit for levator avulsion repair
US6808486B1 (en) Surgical instrument for treating female urinary stress incontinence
EP1715809B1 (en) Prolapse repair
AU2008203927B2 (en) Methods for installing sling to treat fecal incontinence, and related devices
US20130281770A1 (en) Implants And Procedures For Treatment Of Pelvic Floor Disorders
US20090247816A1 (en) Implantable sling for the treatment of incontinence and method of using the same
CN104814807B (en) Pelvic implants transportation system
US10085742B2 (en) Adjustable device for delivering implants and methods of delivering implants
US10245134B2 (en) Apparatus and methods for the treatment of urinary incontinence
AU2014200010B2 (en) Methods for Installing Sling To Treat Fecal Incontinence, and Related Devices
AU2006269717A1 (en) Implantable sling for the treatment of incontinence and method of using the same

Legal Events

Date Code Title Description
AS Assignment

Owner name: AMS RESEARCH, LLC, MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:AMS RESEARCH CORPATION;REEL/FRAME:037300/0728

Effective date: 20141217

AS Assignment

Owner name: APHRODITE WOMEN'S HEALTH, LLC, MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMS RESEARCH, LLC;REEL/FRAME:037551/0626

Effective date: 20150227

Owner name: ASTORA WOMEN'S HEALTH, LLC, MINNESOTA

Free format text: CHANGE OF NAME;ASSIGNOR:APHRODITE WOMEN'S HEALTH, LLC;REEL/FRAME:037551/0749

Effective date: 20150929

AS Assignment

Owner name: AMS RESEARCH, LLC, MINNESOTA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE CONVEYING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 037300 FRAME: 0728. ASSIGNOR(S) HEREBY CONFIRMS THE CHANGE OF NAME;ASSIGNOR:AMS RESEARCH CORPORATION;REEL/FRAME:042308/0630

Effective date: 20141217

AS Assignment

Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE, DELAWARE

Free format text: SECURITY INTEREST;ASSIGNOR:ASTORA WOMEN'S HEALTH, LLC;REEL/FRAME:042743/0278

Effective date: 20170427

Owner name: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATE

Free format text: SECURITY INTEREST;ASSIGNOR:ASTORA WOMEN'S HEALTH, LLC;REEL/FRAME:042743/0278

Effective date: 20170427

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION